Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company, received positive news regarding its CF33-hNIS (VAXINIA) technology. The technology was chosen for presentation at the 2024 Cholangiocarcinoma Foundation Annual Conference in Sydney, Australia. This selection signifies the growing interest in VAXINIA’s potential as a treatment option for cholangiocarcinoma, a rare and aggressive cancer of the bile ducts.
The presentation will occur during the Basic Science Research Seminar Abstract Session on Thursday, April 18th, 2024. Imugene will deliver a short oral presentation followed by a poster display. The presentation will focus on the findings of a study titled “CF33-hNIS, a novel oncolytic virus for the treatment of cholangiocarcinoma and biliary tract malignancies.” This study’s results suggest that VAXINIA when used as a monotherapy (single treatment), may offer a safe and effective approach to treating cholangiocarcinoma and other malignancies of the gastrointestinal (GI) tract.
The Cholangiocarcinoma Foundation Annual Conference serves as a key platform for advancing research and knowledge about cholangiocarcinoma. Imugene’s VAXINIA technology’s selection for presentation at this prestigious event highlights the potential significance of this innovative treatment approach for patients battling this challenging disease.
Cholangiocarcinoma is a relatively uncommon cancer with a significant unmet medical need. Current treatment options are often limited in their effectiveness, and the prognosis for patients remains poor. The potential of VAXINIA to offer a new and potentially more successful treatment option is a welcome development for both researchers and patients alike.
Imugene’s participation in the Cholangiocarcinoma Foundation Conference represents an important opportunity to showcase the progress made with VAXINIA technology. The presentations will likely generate significant interest within the scientific community and potentially pave the way for further research and development efforts.
n recent years, Industry 4.0 has become a popular buzzword in the manufacturing industry, and for a good reason. The fourth industrial revolution …
The ability to manage one’s financial conditions is driving the adoption of AI in personal finance – consumers are starving for financial …
In today’s global economy, supply chains have become increasingly complex and interconnected, making them vulnerable to natural …
Manufacturing processes are now more adaptable, energy-efficient, and environmentally friendly thanks to the development of numerous …